Engineering Industrial Placement

Not Interested
Bookmark
Report This Job

profile Job Location:

Stevenage - UK

profile Monthly Salary: Not Disclosed
Posted on: 19 hours ago
Vacancies: 1 Vacancy

Job Summary

Application Deadline
March 08 2026
Department
Office of Chief Manufacturing Officer
Employment Type
Fixed Term Contract
Location
Stevenage (SMIC)
Workplace type
Onsite
Compensation
25000 / year

Key Responsibilities

Skills Knowledge and Expertise

About Cell and Gene Therapy Catapult

The Cell and Gene Therapy Catapult (CGT Catapult) is an independent innovation and technology organisation committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector.
With experts covering all aspects of advanced therapies it applies its unique capabilities and assets collaborates with academia industry and healthcare providers to develop new technology and innovation.
The Cell and Gene Therapy Catapult works with Innovate UK.

Documents

CGT Catapult is committed to providing an equal diverse and inclusive work environment where everyones contributions are valued. We celebrate differences empower and inspire everyone because when everyone is included everyone 2024 we received bronze accreditation from Inclusive Employers.

Required Experience:

IC

Application DeadlineMarch 08 2026DepartmentOffice of Chief Manufacturing OfficerEmployment TypeFixed Term ContractLocationStevenage (SMIC)Workplace typeOnsiteCompensation25000 / year Key Responsibilities Skills Knowledge and Expertise About Cell and Gene Therapy ...
View more view more

Key Skills

  • Environmental Safety
  • Fire Safety
  • Benefits & Compensation
  • Inspection
  • Ims

About Company

Company Logo

LATEST INSIGHTS Read more Publication PROSPECTUS Read our latest Prospectus for a summary of our offerings across the Innovate UK Catapult Network.

View Profile View Profile